Sichuan University
2 clinical trials · 2 recruiting · OTHER
Trials by Sichuan University
RECRUITINGPhase 2NCT06769971
Phase II Study of Ivonescimab and Cadonilimab in Combination with Chemotherapy in Patients with ES-SCLC
This is a phase II study. All patients are treatment naive extensive stage small cell lung cancer(ES-SCLC), Eastern Cooperative Oncology Group (ECOG) performance status 0-1. The...
Sponsor: Sichuan UniversityEnrolling: 801 location
Small Cell Lung Cancer
RECRUITINGPhase 1NCT06344156
Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer
The aim of this single center, single arm and prospective study is to explore the safety and efficacy of Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy in postoperative...
Sponsor: Sichuan UniversityEnrolling: 431 location
Pancreatic CancerAdjuvant Therapy